======= CHST2 =======
== Gene Information ==
* **Official Symbol**: CHST2
* **Official Name**: carbohydrate sulfotransferase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9435|9435]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y4C5|Q9Y4C5]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CHST2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CHST2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/603798|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This locus encodes a sulfotransferase protein. The encoded enzyme catalyzes the sulfation of a nonreducing N-acetylglucosamine residue, and may play a role in biosynthesis of 6-sulfosialyl Lewis X antigen. [provided by RefSeq, Aug 2011].
* **UniProt Summary**: Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues within keratan-like structures on N-linked glycans and within mucin-associated glycans that can ultimately serve as SELL ligands. SELL ligands are present in high endothelial cells (HEVs) and play a central role in lymphocyte homing at sites of inflammation. Participates in biosynthesis of the SELL ligand sialyl 6-sulfo Lewis X and in lymphocyte homing to Peyer patches. Has no activity toward O-linked sugars. Its substrate specificity may be influenced by its subcellular location. Sulfates GlcNAc residues at terminal, non-reducing ends of oligosaccharide chains. {ECO:0000269|PubMed:11042394}.
|Sulfotransfer 1|
|intrinsic component of Golgi membrane|
|N-acetylglucosamine 6-O-sulfotransferase activity|
|N-acetylglucosamine metabolic process|
|glucosamine-containing compound metabolic process|
|keratan sulfate biosynthetic process|
|sulfotransferase activity|
|keratan sulfate metabolic process|
|amino sugar metabolic process|
|glycosaminoglycan biosynthetic process|
|mucopolysaccharide metabolic process|
|aminoglycan biosynthetic process|
|glycosaminoglycan metabolic process|
|aminoglycan metabolic process|
|trans-Golgi network|
|sulfur compound biosynthetic process|
|sulfur compound metabolic process|
|carbohydrate metabolic process|
|inflammatory response|
|carbohydrate derivative biosynthetic process|
|Golgi membrane|
|Golgi apparatus|
|oxoacid metabolic process|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|defense response|
|organonitrogen compound biosynthetic process|
|small molecule metabolic process|
|macromolecule biosynthetic process|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 10893
* **Expression level (log2 read counts)**: 9.17
{{:chemogenomics:nalm6 dist.png?nolink |}}